BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2559246)

  • 1. Deficiency of pyrimidine 5'-nucleotidase in human leukocytes.
    de Korte D; van Doorn CC; Sijstermans JM; van Gennip AH; Roos D
    J Inherit Metab Dis; 1989; 12(3):267-72. PubMed ID: 2559246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrimidine 5'-nucleotidase deficiency: improved detection of carriers.
    de Korte D; Sijstermans JM; Seip M; van Doorn CC; van Gennip AH; Roos D
    Clin Chim Acta; 1989 Sep; 184(2):175-80. PubMed ID: 2557985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of lead exposure in workers at a lead-acid battery factory in Korea: with focus on activity of erythrocyte pyrimidine 5'-nucleotidase (P5N).
    Kim Y; Harada K; Ohmori S; Lee BK; Miura H; Ueda A
    Occup Environ Med; 1995 Jul; 52(7):484-8. PubMed ID: 7670624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pyrimidine 5'-nucleotidase deficiency as the congenital cause of nonspherocytic hemolytic anemia].
    Pekrun A; Lakomek M; Eng W; Schröter W
    Dtsch Med Wochenschr; 1993 Sep; 118(36):1276-80. PubMed ID: 8375297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced activity of pyrimidine 5'-nucleotidase in rat red blood cells during erythropoiesis.
    Hokari S; Miyazaki T; Hasegawa M; Komoda T
    Biol Chem; 1998 Mar; 379(3):329-33. PubMed ID: 9563829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemolytic anemia caused by pyrimidine 5'-nucleotidase (P5N) deficiency 15 years later. Apropos of 2 new cases of hereditary deficit and another one of lead poisoning].
    de la Serna FJ; Gilsanz F; Ricard P; Urrutia A
    Med Clin (Barc); 1989 Oct; 93(10):380-2. PubMed ID: 2558262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythrocyte nucleotides in lead workers.
    Ichiba M; Tomokuni K; Mori K
    Int Arch Occup Environ Health; 1992; 63(6):419-21. PubMed ID: 1544691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on erythrocyte pyrimidine 5'-nucleotidase (P5N) test and its evaluation in workers occupationally exposed to lead.
    Ichiba M; Tomokuni K
    Int Arch Occup Environ Health; 1990; 62(4):305-10. PubMed ID: 2379961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of Japanese variants of pyrimidine 5'-nucleotidase deficiency.
    Kanno H; Takizawa T; Miwa S; Fujii H
    Br J Haematol; 2004 Jul; 126(2):265-71. PubMed ID: 15238149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic non-spherocytic haemolytic anaemia due to congenital pyrimidine 5' nucleotidase deficiency: 25 years later.
    Vives i Corrons JL
    Baillieres Best Pract Res Clin Haematol; 2000 Mar; 13(1):103-18. PubMed ID: 10916681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetic basis of the interaction between pyrimidine 5' nucleotidase I deficiency and hemoglobin E.
    Escuredo E; Marinaki AM; Duley JA; Thein SL; Rees DC
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1261-3. PubMed ID: 15571242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte pyrimidine 5'-nucleotidase inhibition by acute lead exposure in neonatal rats.
    Konantakieti C; Beuthin FC; Louis-Ferdinand RT
    J Biochem Toxicol; 1986 Sep; 1(3):51-9. PubMed ID: 2856073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Report of the first case of pyrimidine 5' nucleotidase deficiency from Kuwait detected by a screening test. A case report.
    Ghosh K; Abdul Rahman HI; Torres EC; Abdul Wahab A; Hassanein AA
    Haematologia (Budap); 1991; 24(4):229-33. PubMed ID: 1844231
    [No Abstract]   [Full Text] [Related]  

  • 14. Chromatographic analysis of human erythrocyte pyrimidine 5'-nucleotidase from five patients with pyrimidine 5'-nucleotidase deficiency.
    Hirono A; Fujii H; Natori H; Kurokawa I; Miwa S
    Br J Haematol; 1987 Jan; 65(1):35-41. PubMed ID: 3028466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrimidine nucleotides impair phosphoribosylpyrophosphate (PRPP) synthetase subunit aggregation by sequestering magnesium. A mechanism for the decreased PRPP synthetase activity in hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency.
    Lachant NA; Zerez CR; Tanaka KR
    Biochim Biophys Acta; 1989 Jan; 994(1):81-8. PubMed ID: 2535789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pyrimidine-5'-nucleotidase anomaly].
    Miwa S
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):625-8. PubMed ID: 2855950
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of hexose monophosphate shunt in young erythrocytes by pyrimidine nucleotides in hereditary pyrimidine 5' nucleotidase deficiency.
    David O; Ramenghi U; Camaschella C; Vota MG; Comino L; Pescarmona GP; Nicola P
    Eur J Haematol; 1991 Jul; 47(1):48-54. PubMed ID: 1868914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics reveals reduced expression of transketolase in pyrimidine 5'-nucleotidase deficient patients.
    Barasa BA; van Oirschot BA; Bianchi P; van Solinge WW; Heck AJ; van Wijk R; Slijper M
    Proteomics Clin Appl; 2016 Aug; 10(8):859-69. PubMed ID: 27381654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemolytic anemia due to abnormalities in erythrocyte nucleotide metabolism].
    Masuda M; Mizoguchi H
    Nihon Rinsho; 1996 Sep; 54(9):2473-7. PubMed ID: 8890581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrimidine 5'-nucleotidase acquired deficiency in beta-thalassaemia: involvement of enzyme-SH groups in the inactivation process.
    Vives-Corrons JL; Pujades MA; Colomer D
    Acta Haematol; 1990; 83(4):215. PubMed ID: 2115721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.